| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a5c30953166c73ee8ff4abcccb9ed98 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247e325b55c60af988507ff1c8642e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_752f6cad2992eb2a4d4694615e923faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a2f8d47bc556638e37675cc6dc8a3c |
| publicationDate |
2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7005446-B1 |
| titleOfInvention |
Use of AP-1 activators to treat glaucoma and ocular hypertension |
| abstract |
Compositions comprising AP-1 activators and methods of use for treating glaucoma and ocular hypertension are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012024419-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252793-B2 |
| priorityDate |
1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |